Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Analgesic Effect of Intramyometrial Botulinum Toxin Injection Via Hysteroscopy in Pelvic Pain Suggestive of Dysmenorrhea: A Prospective, Multicenter, Double-Blind, Randomized Placebo-Controlled Study.

NCT06995287 is registered in ClinicalTrials.gov with Nantes University Hospital as lead sponsor.

NCT NCT06995287
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06995287 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Analgesic Effect of Intramyometrial Botulinum Toxin Injection Via Hysteroscopy in Pelvic Pain Suggestive of Dysmenorrhea: A Prospective, Multicenter, Double-Blind, Randomized Placebo-Controlled Study.
Lead sponsor
Nantes University Hospital
Phase
Phase 3
Overall status
Recruiting
Start date
February 9, 2026
Completion date
September 9, 2028
Enrollment
222 (estimated)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

chronic pelvic pain, primary dysmenorrhea